CC
TMO icon

Colrain Capital’s Thermo Fisher Scientific TMO Stock Holding History

Colrain Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,500
Closed -$917K – 88
2015
Q3 		$917K Buy
+7,500
New +$977K 0.1% 66

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Colrain Capital's TMO Position: Q4 2015 in Review

Colrain Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2015, closing a stake of 7,500 shares — an estimated $917K sold.

Colrain Capital first reported a position in TMO in Q3 2015 and held it in 1 quarter. The position peaked at $917K in Q3 2015. 1,006 funds tracked by Wall St. Rank hold TMO as of Q4 2015.

  • Colrain Capital reported no remaining Thermo Fisher Scientific position as of Q4 2015 after selling out during the quarter.
  • Colrain Capital sold 7,500 Thermo Fisher Scientific shares in Q4 2015, an estimated $917K.
  • Colrain Capital first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 1 quarter.
  • Colrain Capital's Thermo Fisher Scientific position peaked at $917K in Q3 2015.
  • 1,006 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2015.

Based on Colrain Capital's 13F filing for Q4 2015, filed 5 Feb 2016.